Abstract
Although older adults are sometimes believed to have the lowest rates of alcohol abuse as an age cohort, the prevalence of alcohol use and abuse in this group is clearly underestimated. The under-diagnosis of alcohol abuse is due, in part, to the facts that the effects of alcohol use among older adults tend to be less clearly visible than among other age groups and that older adults are less likely to seek treatment than younger age groups. An additional challenge to diagnosis may be a lack of previous alcohol abuse by the patient, as approximately one-third of older adults with alcohol-use problems first develop their drinking problem after the age of 60 years. With a demographic shift that is expected to increase the number of older adults with alcohol problems, the awareness and understanding of this problem becomes increasingly important.
Under-diagnosis of problem drinking in older adults is particularly unfortunate because the risks associated with alcohol abuse and relapse for the elderly are significant. Relapse, or the return to drinking following abstinence, may follow situations that are of particularly high risk for older adults. These include situations related to anxiety, interpersonal conflict, depression, loneliness, loss or social isolation. By helping patients to monitor these high-risk situations, to identify strategies that have been successful in promoting abstinence in the past, and to become engaged in treatment, relapse may be avoided and abstinence maintained.
Treatments such as cognitive-behavioural therapy, group and family therapies and self-help groups are just as effective for older adults as they are for other age groups. In fact, group and family therapies and self-help groups may be of particular benefit to older adults because of the emphasis on social support. Medicinal adjuncts are also equally effective in the elderly, but strict compliance and careful monitoring of adverse effects are especially important in patients who take multiple medications. Because of their benign adverse effect profiles, naltrexone and acamprosate are particularly good pharmacological agents for relapse prevention in older adults.
Similar content being viewed by others
References
American Psychological Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): APA, 1994
World Health Organization. The ICD-10 classification of mental and behavioral disorders. Geneva: WHO, 1992
Johnson I. Alcohol problems in old age: a review of recent epidemiological research. Int J Geriatr Psychiatry 2000; 15: 575–81
Allen D, Landis R. Substance abuse in elderly individuals. In: Nussbaum D, editor. The handbook of neuropsychology and aging. New York (NY): Plenum Press, 1997
Patterson T, Jeste D. The potential impact of the baby-boom generation on substance abuse among elderly persons. J Ment Health Aging 1999; 50: 1184–8
Office of Population Censuses and Surveys. Living in Britain: results from the 1994 general household survey. London: HMSO, 1996
MacNeil P, Webster I. Canada’s alcohol and other drugs survey: a discussion of the findings. Ottawa (ONT): Office of Alcohol, Drugs, and Dependency Issues, 1994
National Institute on Alcohol Abuse and Alcoholism. Ninth special report to the United States Congress on alcohol and health. Washington (DC): US Government Printing Office, 1997
Giordano J, Beckham K. Alcohol use and abuse in old age: an examination of type II alcoholism. J Gerontol Soc Work 1985; 9(1): 65–83
Chermack ST, Blow FC, Hill EM, et al. The relationship between alcohol symptoms and consumption among older drinkers. Alcohol Clin Exp Res 1996; 20: 1153–8
Blow F, Cook C, Booth B, et al. Age-related psychiatric comorbidities and level of functioning in alcoholic veterans seeking outpatient treatment. Hosp Community Psychiatry 1992; 43: 990–5
Schonfeld L, Dupree L. Alcohol use and misuse in older adults. Rev Clin Gerontol 1999; 9: 151–62
Bucholz K, Sheline Y, Heltzer J. The epidemiology of alcohol use, problems, and dependence in elders: a review. In: Beresford T, Gomberg E, editors. Alcohol and aging. New York (NY): Oxford University Press, 1995
Liberto J, Oslin D, Ruskin P. Alcoholism in older persons: a review of the literature. Hosp Community Psychiatry 1992; 43: 975–84
Joseph C. Misuse of alcohol and drugs in the nursing home. In: Gurnack A, editor. Older adults’ misuse of alcohol, medicines, and other drugs: research and practice issues. New York (NY): Springer Publishing Co, Inc, 1997: 228–54
Gomberg E, Zucker R. Substance use and abuse in old age. In: Nordhus I, VandenBos G, Berg S, et al., editors. Clinical geropsychology. Washington (DC): American Psychological Association, 1998
Liberto J, Oslin D. Early versus late onset of alcoholism in the elderly. In: Gurnack A, editor. Drugs and the elderly: use and abuse of drugs, medicines, alcohol, and tobacco. New York (NY): Springer, 1996
Sobell M, Sobell L. Controlled drinking after 25 years: how important was the great debate? Addiction 1995; 90: 1149–53
Marlatt GA, Gordon JR. Relapse prevention. New York (NY): The Guilford Press, 1985
Litman GK. Relapse in alcoholism: traditional and current approaches. In: Edwards G, Grant M, editors. Alcoholism treatment in transition. Baltimore (MD): University Park Press, 1980
Hunt WA, Barnett W, Branch LG. Relapse rates in addiction programs. J Clin Psychol 1971; 27: 455–6
Armor D, Polich J, Stambul H. Alcoholism and treatment. New York (NY): Wiley, 1978
Orford J, Edwards G. Alcoholism: a comparison of treatment and advice, with a study of influence of marriage (Maudsley Monographs No. 26). New York (NY): Oxford University Press, 1977
Moos RH, Finney JW, Cronkite RC. Alcoholism treatment: context, process and outcome. New York (NY): Oxford University Press, 1990
Polich JM, Armor DJ, Braiker HB. The course of alcoholism: four years after treatment. New York (NY): Wiley, 1981
Janik SW, Dunham RG. A nationwide examination of the need for specific alcoholism treatment programs for the elderly. J Stud Alcohol 1983; 44: 307–17
Marlatt GA, Gordon JR. Determinants of relapse: implications for the maintenance of behavior change. In: Davidson PO, Davidson SM, editors. Behavioral medicine: changing health lifestyles. New York (NY): Brunner/Mazel, 1980: 410–52
Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 1977; 84: 191–215
Lowman C, Allen J, Stout RL, et al. Replication and extension of Marlatt’s taxonomy of relapse precipitants: overview of procedures and results. Addiction 1996; 91: S51–71
Schonfeld L, Dupree L, Rohrer G. Age-related differences between younger and older alcohol abusers. J Clin Gerontol 1995; 1: 219–27
Brown SA, Goldman MS, Inn A, et al. Expectations of reinforcement from alcohol: their domain and relation to drinking patterns. J Consult Clin Psychol 1980; 48: 419–26
Storandt M, VandenBos G. Neuropsychological assessment of dementia and depression. Washington (DC): American Psychological Association, 1995
Rice C, Longabaugh R, Beattie M, et al. Age group differences in response to treatment for problematic alcohol use. Addiction 1993; 88: 1369–75
McKay JR, Maisto SA, O’Farrell TJ. Alcoholics’ perceptions of factors in the onset and termination of relapses and the maintenance of abstinence: results from a 30-month follow-up. Psychol Addict Behav 1996; 10: 167–80
Connors GJ, Maisto SA, Zywiak WH. Male and female alcoholics’ attributions regarding the onset and termination of relapses and the maintenance of abstinence. J Subst Abuse 1998; 10: 27–42
Connors GJ, Maisto SA, Zywiak WH. Understanding relapse in the broader context of posttreatment functioning. Addiction 1996; 91: S173–89
Litman GK, Eiser JR, Rawson NSB, et al. Towards a typology of relapse: differences in relapse and coping behaviours between alcoholic relapsers and survivors. Behav Res Ther 1979; 17: 89–94
Blow F, Walton M, Barry K, et al. The relationship between alcohol problems and health functioning of older adults in primary care settings. J Am Geriatr Soc 2000; 48: 769–74
Brower K, Mudd S, Blow F, et al. Severity and treatment of alcohol withdrawal in elderly versus younger patients. Alcohol Clin Exp Res 1994; 18: 196–201
Oslin D, Liberto J, O’Brien J, et al. Naltrexone as an adjunctive treatment for older patients with alcohol dependence. Am J Geriatr Psychiatry 1997; 5: 324–32
Monti P, Abrams D, Kadden R, et al. Treating alcohol dependence: a coping skills training guide. New York (NY): The Guilford Press, 1989
Nirenberg T, Lisansky-Gomberg E, Cellucci T. Substance abuse disorders. In: Hersen M, Van Hasselt V, editors. Handbook of clinical geropsychology: the Plenum series in adult development and aging. New York (NY): Plenum Press, 1998
Dupree L, Broskowski H, Scholfeld L. The gerontology alcohol project: a behavioral program for elderly alcohol abusers. Gerontologist 1984; 24: 510–6
Johnson L. How to diagnose and treat chemical dependency in the elderly. J Gerontol Nurs 1989; 15: 22–6
Zimberg S. The elderly. In: Washton A, editor. Psychotherapy and substance abuse. New York (NY): The Guilford Press, 1995
Swift RM. Drug therapy for alcohol dependence. N Engl J Med 1999; 340: 1482–90
Kranzler H. Pharmacotherapy of alcoholism: gaps in knowledge and opportunities for research. Alcohol Alcohol 2000; 35: 537–47
Brewer C, Meyers R Johnsen J. Does disulfiram help to prevent relapse in alcohol abuse? CNS Drugs 2000; 14: 329–41
Chick J, Gough K, Falkowski W, et al. Disulfiram treatment for alcoholism. Br J Psychiatry 1993; 161: 84–9
Brewer C. How effective is the standard dose of disulfiram? A review of the alcohol-disulfiram reaction in practice. Br J Psychiatry 1984; 144: 200–2
Fuller R, Branchey L, Brightwell D. Disulfiram treatment of alcoholism: a veterans administration cooperative study. JAMA 1986; 256: 1449–55
Johnsen J, Morland J. Disulfiram implant: a double-blind placebo controlled follow-up on treatment outcome. Alcohol Clin Exp Res 1991; 15: 532–6
O’Farrell T, Allen J, Litten R. Disulfiram (antabuse) contracts in treatment of alcoholism. NIDA Res Monogr 1995; 150: 65–91
Garbutt J, West S, Carey T, et al. Pharmacological treatment of alcohol dependence: a review of the evidence. JAMA 1999; 281: 1318–25
Herz A. Endogenous opioid systems and alcohol addiction. Psychopharmacology 1997; 129: 99–111
King A, Volpicelli J, Frazer A, et al. Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence. Psychopharmacology 1997; 129: 15–22
Swift R, Whelihan W, Kuznetsov O, et al. Naltrexone-induced alterations in human ethanol intoxication. Am J Psychiatry 1994; 151: 1463–7
Volpicelli J, Watson N, King A, et al. Effect of naltrexone on alcohol “high” in alcoholics. Am J Psychiatry 1995; 152: 613–5
Monti P, Rohsenow D, Hutchison K, et al. Naltrexone’s effect on cue-elicited craving among alcoholics in treatment. Alcohol Clin Exp Res 1999; 23: 1386–94
Davidson D, Swift R, Fitz E. Naltrexone increases the latency to drink alcohol in social drinkers. Alcohol Clin Exp Res 1996; 20: 732–9
Mason B, Ritvo E, Morgan R, et al. A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence. Alcohol Clin Exp Res 1994; 18: 1162–7
O’Malley S, Jaffee A, Chang G, et al. Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry 1992; 40: 894–8
Tempesta E, Janiri L, Bignamini A, et al. Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study. Pharmacopsychiatry 2000; 29: 27–9
Whitworth A, Fischer F, Lesch OM, et al. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet 1996; 347: 1438–42
Geerlings PJ, Ansoms C, van den Brink W. Acamprosate and prevention of relapse in alcoholics: results of a randomized, placebo controlled, double-blind study in out-patient alcoholics in the Netherlands, Belgium and Luxembourg. Eur Addict Res 1997; 3(3): 129–37
Lhuintre JP, Moore ND, Tran G, et al. Acamprosate appears to decrease alcohol intake in weaned alcoholics. Alcohol Alcohol 1990; 25(6): 613–22
Paille FM, Guelfi JD, Perkins AC, et al. Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. Alcohol 1995; 30(2): 239–47
Pelc I, Verbanck P, LeBon O, et al. Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients. A 90-day placebo controlled dose-finding study. Br J Psychiatry 1997; 171: 73–7
Sass H, Soyka M, Mann K, et al. Relapse prevention by acamprosate: results from a placebo-controlled study on alcohol dependence. Arch Gen Psychiatry 1996; 53(8): 673–80
Soyka M. Clinical efficacy of acamprosate in the treatment of alcoholism. In: Soyka M, editor. Acamprosate in relapse prevention of alcoholism. Berlin: Springer-Verlag, 1996: 155–71
Saivin S, Hulot T, Chabac S, et al. Clinical pharmacokinetics of acamprosate. Clin Pharmacokinet 1998; 35(5): 331–45
Acknowledgements
Preparation of this manuscript was supported, in part, with funding awarded as part of a grant from the US National Institute on Alcohol Abuse and Alcoholism (NIAAA) to the Research Institute of Addictions, University at Buffalo (Award No. AA11529).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barrick, C., Connors, G.J. Relapse Prevention and Maintaining Abstinence in Older Adults with Alcohol-Use Disorders. Drugs Aging 19, 583–594 (2002). https://doi.org/10.2165/00002512-200219080-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-200219080-00004